Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review

BACKGROUND: Unabridged access to drug industry and regulatory trial registers and data reduces reporting bias in systematic reviews and may provide a complete index of a drug’s clinical study programme. Currently, there is no public index of the human papillomavirus (HPV) vaccine industry study prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Lars, Gøtzsche, Peter C., Jefferson, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774129/
https://www.ncbi.nlm.nih.gov/pubmed/29347995
http://dx.doi.org/10.1186/s13643-018-0675-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774129/
https://www.ncbi.nlm.nih.gov/pubmed/29347995
http://dx.doi.org/10.1186/s13643-018-0675-z

Ejemplares similares